Monday, August 3, 2026
Biotech

AstraZeneca, Bristol Myers Squibb Discuss Big Merger

AstraZeneca may merge with Bristol Myers Squibb in a deal worth $400 billion.

Big drug companies AstraZeneca and Bristol Myers Squibb are talking about joining together. This could create a giant new company. The deal could be worth $400 billion.

AstraZeneca is based in the UK. Bristol Myers Squibb is a US company. Both companies make important medicines. A merger would change the drug industry.

This move would make one of the largest drug makers in the world. It could affect many patients. It would also change how these companies develop new treatments. The talks are still early. We will watch for more news on this possible big deal.

Source: CNBC

#Biotech#Mergers and Acquisitions

More from Biotech